Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
67 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-GUANFACINE XR | 2MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-08 | 2024-01-12 | 212949 |
| APO-GUANFACINE XR | 4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-15 | 2024-01-12 | 213559 |
| APO-GUANFACINE XR | 3MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-22 | 2024-01-12 | 214220 |
| APO-GUANFACINE XR | 2MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-22 | 2024-01-12 | 214232 |
| APO-GUANFACINE XR | 1MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-10-06 | 2024-01-12 | 206579 |
| APO-GUANFACINE XR | 1MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-06 | 2024-01-12 | 209339 |
| APO-HALOPERIDOL TAB 10MG | 10MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18945 |
| APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18184 |
| APO-HYDRALAZINE | 50MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18187 |
| APO-HYDRALAZINE | 10MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18190 |
| APO-HYDRALAZINE | 50MG | TABLET TABLET | Resolved | 2022-10-28 | 2023-01-06 | 172882 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2022-11-11 | 2022-12-23 | 174332 |
| APO-HYDRALAZINE | 10MG | TABLET TABLET | Resolved | 2022-11-27 | 2022-12-23 | 175889 |
| APO-HYDRALAZINE | 50MG | TABLET TABLET | Resolved | 2025-01-09 | 2025-02-07 | 247379 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-05-24 | 2024-06-14 | 228804 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-06-27 | 2024-09-20 | 231481 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2021-05-25 | 2021-07-15 | 139842 |
| APO-HYDRALAZINE | 50MG | TABLET TABLET | Resolved | 2021-06-18 | 2021-07-15 | 141238 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2023-09-22 | 2023-11-06 | 204999 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-01-19 | 2024-04-05 | 216650 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |